Sana Biotechnology (SANA) Change in Account Payables (2020 - 2026)
Sana Biotechnology (SANA) reported Change in Account Payables of $454000.0 for Q1 2026, up 110.75% on a YoY basis from $215423.1 in Q1 2025, and up 340.21% sequentially from -$189000.0 in Q4 2025.
Sana Biotechnology (SANA) Change in Account Payables (2020 - 2026) Analysis & Trends
Sana Biotechnology (SANA) has 7 years of Change in Account Payables data on file, last reported at $454000.0 in Q1 2026.
- For the quarter ending Q1 2026, Change in Account Payables rose 110.75% year-over-year to $454000.0; the trailing twelve-month figure through Mar 2026 stood at $1.1 million (up 163.54% YoY), and the FY2025 full-year result was -$3.5 million, down 357.44% from the prior year.
- Change in Account Payables climbed to $454000.0 in Q1 2026, from -$189000.0 in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $2.3 million in Q4 2024 to a low of -$4.2 million in Q1 2025.
- A 5-year average of $21823.5 and a median of -$189000.0 in 2025 frame the typical range for Change in Account Payables.
- Across the five-year window, Change in Account Payables jumped 270.73% in 2024 and tumbled 296.99% in 2025, its largest moves.
- Tracing SANA's Change in Account Payables over 5 years: stood at -$1.1 million in 2022, then slipped by 23.02% to -$1.3 million in 2023, then jumped by 270.73% to $2.3 million in 2024, then sank by 108.29% to -$189000.0 in 2025, then soared by 340.21% to $454000.0 in 2026.
- Business Quant data shows SANA's Change in Account Payables at $454000.0 in Q1 2026, -$189000.0 in Q4 2025, and -$357000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,725.60 Bn | 68,725.31 Bn | - | - |
| 2 | Nanobiotix | 1,953.19 Bn | 1,953.13 Bn | - | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - | - |
| 4 | BeOne Medicines | 472.73 Bn | 467.94 Bn | 1.35 Bn | -42.19 Mn |
| 5 | Vertex Pharmaceuticals | 123.52 Bn | 116.27 Bn | 2.59 Bn | 35.60 Mn |
| 6 | Regeneron Pharmaceuticals | 69.74 Bn | 60.99 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 63.09 Bn | 63.09 Bn | - | - |
| 8 | Argenx Se | 56.42 Bn | 51.24 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.76 Bn | 37.76 Bn | - | 16.86 Mn |
| 10 | Sana Biotechnology | 939.93 Mn | 939.93 Mn | - | 454,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 454,000.00 |
| Mar 31, 2026 | 454,000.00 |
| Dec 31, 2025 | -189,000.00 |
| Dec 31, 2025 | -189,000.00 |
| Sep 30, 2025 | -357,000.00 |
| Sep 30, 2025 | -357,000.00 |
| Jun 30, 2025 | 1.23 Mn |
| Jun 30, 2025 | 1.23 Mn |
| Mar 31, 2025 | -4.22 Mn |
| Mar 31, 2025 | -4.22 Mn |
| Dec 31, 2024 | 2.28 Mn |
| Dec 31, 2024 | 2.28 Mn |
| Sep 30, 2024 | -507,000.00 |
| Sep 30, 2024 | -507,000.00 |
| Jun 30, 2024 | 667,000.00 |
| Jun 30, 2024 | 667,000.00 |
| Mar 31, 2024 | -1.06 Mn |
| Mar 31, 2024 | -1.06 Mn |
| Dec 31, 2023 | -1.34 Mn |
| Dec 31, 2023 | -1.34 Mn |